A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association.

This report is the continuation of two earlier reports that defined human arterial intima and precursors of advanced atherosclerotic lesions in humans. This report describes the characteristic components and pathogenic mechanisms of the various advanced atherosclerotic lesions. These, with the earlier definitions of precursor lesions, led to the histological classification of human atherosclerotic lesions found in the second part of this report. The Committee on Vascular Lesions also attempted to correlate the appearance of lesions noted in clinical imaging studies with histological lesion types and corresponding clinical syndromes. In the histological classification, lesions are designated by Roman numerals, which indicate the usual sequence of lesion progression. The initial (type 1) lesion contains enough atherogenic lipoprotein to elicit an increase in macrophages and formation of scattered macrophage foam cells. As in subsequent lesion types, the changes are more marked in locations of arteries with adaptive intimal thickening. (Adaptive thickenings, which are present at constant locations in everyone from birth, do not obstruct the lumen and represent adaptations to local mechanical forces). Type II lesions consist primarily of layers of macrophage foam cells and lipid-laden smooth muscle cells and include lesions grossly designated as fatty streaks. Type III is the intermediate stage between type II and type IV (atheroma, a lesion that is potentially symptom-producing). In addition to the lipid-laden cells of type II, type III lesions contain scattered collections of extracellular lipid droplets and particles that disrupt the coherence of some intimal smooth muscle cells. This extracellular lipid is the immediate precursor of the larger, confluent, and more disruptive core of extracellular lipid that characterizes type IV lesions. Beginning around the fourth decade of life, lesions that usually have a lipid core may also contain thick layers of fibrous connective tissue (type V lesion) and/or fissure, hematoma, and thrombus (type VI lesion). Some type V lesions are largely calcified (type Vb), and some consist mainly of fibrous connective tissue and little or no accumulated lipid or calcium (type Vc).

[1]  J J Albers,et al.  Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. , 1990, The New England journal of medicine.

[2]  M. Fishbein,et al.  Detection and localization of tumor necrosis factor in human atheroma. , 1990, The American journal of cardiology.

[3]  Steven E. Nissen,et al.  Intravascular Ultrasound Assessment of Lumen Size and Wall Morphology in Normal Subjects and Patients With Coronary Artery Disease , 1991, Circulation.

[4]  G. E. Newman,et al.  Correlation of clinical history with quantitative histology of lower extremity atheroma biopsies obtained with the Simpson atherectomy catheter. , 1989, Atherosclerosis.

[5]  A. Becker,et al.  Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. , 1994, Circulation.

[6]  P. Cohn,et al.  Clinical significance of coronary arterial ectasia. , 1976, The American journal of cardiology.

[7]  J. Betteridge Nutrition and platelet function in atherogenesis , 1987, Proceedings of the Nutrition Society.

[8]  V. Fuster,et al.  The Role of Collateral Circulation in the Various Coronary Syndromes , 1979, Circulation.

[9]  Louis E. Teichholz,et al.  Angiographie morphology and the pathogenesis of unstable angina pectoris , 1985 .

[10]  M. Aviram,et al.  Platelet activation by plasma lipoproteins. , 1987, Progress in cardiovascular diseases.

[11]  W. Wagner,et al.  A Proposed Structure of Chondroitin 6‐Sulfate Proteoglycan of Human Normal and Adjacent Atherosclerotic Plaque , 1986, Arteriosclerosis.

[12]  F. Keeley,et al.  Amino acid composition and calcification of human aortic elastin. , 1974, Atherosclerosis.

[13]  J P Binette,et al.  Chemical and physicochemical studies on the mineral deposits of the human atherosclerotic aorta. , 1980, Atherosclerosis.

[14]  P C Elwood,et al.  Fibrinogen, Viscosity, and White Blood Cell Count Are Major Risk Factors for Ischemic Heart Disease: The Caerphilly and Speedwell Collaborative Heart Disease Studies , 1991, Circulation.

[15]  D. Ku,et al.  Hemodynamics and atherosclerosis. Insights and perspectives gained from studies of human arteries. , 1988, Archives of pathology & laboratory medicine.

[16]  E. J. Miller,et al.  Quantitation of type I, III, and V collagens in human tissue samples by high-performance liquid chromatography of selected cyanogen bromide peptides. , 1991, Analytical biochemistry.

[17]  K. Murata,et al.  Collagen types in various layers of the human aorta and their changes with the atherosclerotic process. , 1986, Atherosclerosis.

[18]  A. Gown,et al.  Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. , 1986, The American journal of pathology.

[19]  W. Hollander,et al.  The glycosaminoglycans of the human artery and their changes in atherosclerosis. , 1976, The Journal of clinical investigation.

[20]  G. Balian,et al.  Collagen characterisation and cell transformation in human atherosclerosis , 1975, Nature.

[21]  J M Johnson,et al.  Natural history of asymptomatic carotid plaque. , 1985, Archives of surgery.

[22]  A. Maseri,et al.  Pre-existing coronary stenoses in patients with first myocardial infarction are not necessarily severe. , 1988, European heart journal.

[23]  G. V. R. Born,et al.  INFLUENCE OF PLAQUE CONFIGURATION AND STRESS DISTRIBUTION ON FISSURING OF CORONARY ATHEROSCLEROTIC PLAQUES , 1989, The Lancet.

[24]  V. Fuster,et al.  Angiographic evolution of coronary artery morphology in unstable angina. , 1986, Journal of the American College of Cardiology.

[25]  E. Falk Morphologic features of unstable atherothrombotic plaques underlying acute coronary syndromes. , 1989, The American journal of cardiology.

[26]  F J Pinto,et al.  Intracoronary Ultrasound in Cardiac Transplant Recipients: In Vivo Evidence of “Angiographically Silent” Intimal Thickening , 1991, Circulation.

[27]  M. Kiefer,et al.  Structure and biological activities of a heparin-derived hexasaccharide with high affinity for basic fibroblast growth factor. , 1993, The Journal of biological chemistry.

[28]  T. Register,et al.  Heterogeneity in glycosylation of dermatan sulfate proteoglycan core proteins isolated from human aorta. , 1990, Connective tissue research.

[29]  U. Welsch,et al.  Analysis of atherectomy specimens. , 1993, The American journal of cardiology.

[30]  A. Marcus,et al.  Vascular transcellular signaling. , 1993, Journal of lipid research.

[31]  J. Weinreb,et al.  Diagnosis of carotid artery stenosis: comparison of 2DFT time-of-flight MR angiography with contrast angiography in 50 patients. , 1991, AJNR. American journal of neuroradiology.

[32]  V. Koteliansky,et al.  Relative distribution of fibronectin and type I, III, IV, V collagens in normal and atherosclerotic intima of human arteries. , 1987, Atherosclerosis.

[33]  P. Angelberger,et al.  In vivo quantification of cholesterol content in human carotid arteries by quantitative gamma-camera imaging after injection of autologous low density lipoproteins (LDL). , 1992, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

[34]  W H Baker,et al.  Elastolytic and collagenolytic studies of arteries. Implications for the mechanical properties of aneurysms. , 1984, Archives of surgery.

[35]  G. Bondjers,et al.  Regional Accumulations of T Cells, Macrophages, and Smooth Muscle Cells in the Human Atherosclerotic Plaque , 1986, Arteriosclerosis.

[36]  S. Schwartz,et al.  968-23 Evaluation of Proliferation in Human Atherectomy Specimens Using In Situ Hybridization for Histone H3 , 1995 .

[37]  H C Smith,et al.  Angiographic occurrence and clinical correlates of intraluminal coronary artery thrombus: role of unstable angina. , 1985, Journal of the American College of Cardiology.

[38]  M. Barnes,et al.  Collagen polymorphism in the normal and diseased blood vessel wall. Investigation of collagens types I, III and V. , 1982, Atherosclerosis.

[39]  R. Mecham,et al.  Chemotactic activity of elastin-derived peptides. , 1980, The Journal of clinical investigation.

[40]  E. Nabel,et al.  Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis. , 1990, Journal of the American College of Cardiology.

[41]  M. Davies,et al.  Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. , 1993, British heart journal.

[42]  J L Witztum,et al.  Low density lipoprotein undergoes oxidative modification in vivo. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[43]  H. Fukushi,et al.  Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. , 1993, The Journal of infectious diseases.

[44]  D. Baim,et al.  Relation between activated smooth-muscle cells in coronary-artery lesions and restenosis after atherectomy. , 1993, The New England journal of medicine.

[45]  G. Miller Hemostasis and cardiovascular risk. The British and European experience. , 1992, Archives of pathology & laboratory medicine.

[46]  S. Bertelsen CHEMICAL STUDIES ON THE ARTERIAL WALL IN RELATION TO ATHEROSCLEROSIS , 1968, Annals of the New York Academy of Sciences.

[47]  E. Lillehoj,et al.  Normal and abnormal aspects of proteinuria. Part I: Mechanisms, characteristics and analyses of urinary protein. Part II: Clinical considerations. , 1986, Experimental pathology.

[48]  A M Lees,et al.  External imaging of human atherosclerosis. , 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[49]  P. Constantinides Plaque Hemorrhages, Their Genesis and Their Role in Supra-Plaque Thrombosis and Atherogenesis , 1990 .

[50]  E. Bolson,et al.  Quantitative Coronary Arteriography: Estimation of Dimensions, Hemodynamic Resistance, and Atheroma Mass of Coronary Artery Lesions Using the Arteriogram and Digital Computation , 1977, Circulation.

[51]  M. Nobuyoshi,et al.  Progression of coronary atherosclerosis: is coronary spasm related to progression? , 1991, Journal of the American College of Cardiology.

[52]  E. Ernst The role of fibrinogen as a cardiovascular risk factor. , 1993, Atherosclerosis.

[53]  A. Barger,et al.  Cinemicrographic Studies of the Vasa Vasorum of Human Coronary Arteries , 1990 .

[54]  H. Weisman,et al.  Imaging of Vascular Injury With 99mTc‐Labeled Monoclonal Antiplatelet Antibody S12: Preliminary Experience in Human Percutaneous Transluminal Angioplasty , 1992, Circulation.

[55]  Tracy Rp,et al.  Thrombosis and cardiovascular risk in the elderly. , 1992 .

[56]  R. Ross,et al.  Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. , 1984, The American journal of pathology.

[57]  H. Kagan,et al.  Regulation of elastase-catalyzed hydrolysis of insoluble elastin by synthetic and naturally occurring hydrophobic ligands. , 1974, Biochemistry.

[58]  S. Thompson,et al.  HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDY , 1980, The Lancet.

[59]  S. Davies,et al.  Irregular coronary lesion morphology after thrombolysis predicts early clinical instability. , 1991, Journal of the American College of Cardiology.

[60]  R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[61]  J. Loscalzo,et al.  Lipoprotein(a). A unique risk factor for atherothrombotic disease. , 1990, Arteriosclerosis.

[62]  B. Jacotot,et al.  In vitro preparation of elastin--triglyceride complexes. Fatty acid uptake and modification of the susceptibility to elastase action. , 1980, Atherosclerosis.

[63]  A. Barger,et al.  Hypothesis: vasa vasorum and neovascularization of human coronary arteries. A possible role in the pathophysiology of atherosclerosis. , 1984, The New England journal of medicine.

[64]  P L Weissberg,et al.  Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells. , 1993, Circulation research.

[65]  M A Schork,et al.  Type I collagen gene expression in human atherosclerosis. Localization to specific plaque regions. , 1993, The American journal of pathology.

[66]  I. Goldberg,et al.  Oligosaccharide sequences of endothelial cell surface heparan sulfate proteoglycan with affinity for lipoprotein lipase. , 1994, The Journal of biological chemistry.

[67]  P. Dicorleto,et al.  Cultured endothelial cells produce a platelet-derived growth factor-like protein. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[68]  H. Bakala,et al.  Effect of Mg2+ and Ca2+ on enzymatic elastolysis of insoluble elastin determined by a conductimetric method. , 1981, Connective tissue research.

[69]  L Morgenstern,et al.  Coronary angioscopy in patients with unstable angina pectoris. , 1986, The New England journal of medicine.

[70]  P. Carlsson,et al.  Identification of Apo B‐100 Segments Mediating the Interaction of Low Density Lipoproteins with Arterial Proteoglycans , 1988, Arteriosclerosis.

[71]  W. Roberts,et al.  Morphologic comparison of frequency and types of acute lesions in the major epicardial coronary arteries in unstable angina pectoris, sudden coronary death and acute myocardial infarction. , 1991, Journal of the American College of Cardiology.

[72]  H. C. Stary Changes in components and structure of atherosclerotic lesions developing from childhood to middle age in coronary arteries. , 1994, Basic research in cardiology.

[73]  V. Fuster,et al.  Myocardial infarction and coronary artery occlusion: a prospective 5-year angiographic study , 1990 .

[74]  C. Zarins,et al.  Role of medial lamellar architecture in the pathogenesis of aortic aneurysms. , 1984, Journal of vascular surgery.

[75]  H. Furthmayr,et al.  The collagenous components of the subendothelium. Correlation of structure and function. , 1980, Laboratory investigation; a journal of technical methods and pathology.

[76]  E. Topol,et al.  Comparison of histopathologic coronary lesions obtained from directional atherectomy in stable angina versus acute coronary syndromes. , 1994, The American journal of cardiology.

[77]  J. Strong,et al.  Technics for studying atherosclerotic lesions. , 1958, Laboratory investigation; a journal of technical methods and pathology.

[78]  F. Roll,et al.  Migrating epidermis produces AB2 collagen and requires continual collagen synthesis for movement , 1979, Nature.

[79]  B L Langille,et al.  Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. , 1986, Science.

[80]  P. Serruys,et al.  Histologic characteristics of tissue excised during directional coronary atherectomy in stable and unstable angina pectoris. , 1993, The American journal of cardiology.

[81]  D. Kiprov,et al.  A study of changes in the number of mast cells in the human arterial wall during the stages of development of atherosclerosis. , 1966, Journal of atherosclerosis research.

[82]  C. Tejada,et al.  The quantitative appraisal of atherosclerosis. , 1957, The American journal of pathology.

[83]  P. Constantinides,et al.  Plaque fissures in human coronary thrombosis , 1966 .

[84]  D. Ku,et al.  Pulsatile Flow and Atherosclerosis in the Human Carotid Bifurcation: Positive Correlation between Plaque Location and Low and Oscillating Shear Stress , 1985, Arteriosclerosis.

[85]  R. Ross,et al.  Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. , 1990, Arteriosclerosis.

[86]  A. Vaheri,et al.  Sequential appearance of fibronectin and collagen in experimental granulation tissue. , 1980, Laboratory investigation; a journal of technical methods and pathology.

[87]  Michael C. Fishbein,et al.  Histopathologic Validation of Angioscopy and Intravascular Ultrasound , 1991, Circulation.

[88]  Y. Koiwaya,et al.  Angiographic features in the infarct-related artery after intracoronary urokinase followed by prolonged anticoagulation. Role of ruptured atheromatous plaque and adherent thrombus in acute myocardial infarction in vivo. , 1988, Circulation.

[89]  T. Kristensen,et al.  Plasma fibrinogen and ischemic heart disease risk factors. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[90]  R. Mecham,et al.  Neointimal macrophages colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries. , 1993, The Journal of clinical investigation.

[91]  D C Levin,et al.  Significance of the Angiographic Morphology of Localized Coronary Stenoses: Histopathologic Correlations , 1982, Circulation.

[92]  W. Santamore,et al.  Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? , 1988, Circulation.

[93]  M. Tammi,et al.  Connective tissue components in normal and atherosclerotic human coronary arteries. , 1978, Atherosclerosis.

[94]  J. Guyton,et al.  The lipid-rich core region of human atherosclerotic fibrous plaques. Prevalence of small lipid droplets and vesicles by electron microscopy. , 1989, The American journal of pathology.

[95]  D. Urry Neutral sites for calcium ion binding to elastin and collagen: a charge neutralization theory for calcification and its relationship to atherosclerosis. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[96]  J R Brookeman,et al.  High‐resolution H NMR spectral signature from human atheroma , 1988, Magnetic resonance in medicine.

[97]  J. Turnbull,et al.  Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. , 1992, The Journal of biological chemistry.

[98]  G. Schmitz,et al.  Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids. , 1991, Journal of lipid research.

[99]  H. C. Stary Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. , 1989, Arteriosclerosis.

[100]  N. Mullani,et al.  Relation between geometric dimensions of coronary artery stenoses and myocardial perfusion reserve in man. , 1987, The Journal of clinical investigation.

[101]  H. C. Stary,et al.  The sequence of cell and matrix changes in atherosclerotic lesions of coronary arteries in the first forty years of life. , 1990, European heart journal.

[102]  M. Tilson Status of research on abdominal aortic aneurysm disease , 1989 .

[103]  V. Fuster,et al.  Insights into the pathogenesis of acute ischemic syndromes. , 1988, Circulation.

[104]  J. Massagué,et al.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.

[105]  M. Davies,et al.  901-120 Plaque Constituents in Patients with Stable and Unstable Angina: An Atherectomy Study , 1995 .

[106]  W. Roberts,et al.  Coronary artery imaging with intravascular high-frequency ultrasound. , 1990, Circulation.

[107]  A. Henney,et al.  Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[108]  D. Waters,et al.  Quantitative Angiographic Morphology of the Coronary Artery Lesions at Risk of Thrombotic Occlusion , 1992, Circulation.

[109]  S. Ellis,et al.  Morphology of left anterior descending coronary territory lesions as a predictor of anterior myocardial infarction: a CASS Registry Study. , 1989, Journal of the American College of Cardiology.

[110]  R. Mesa-Tejada,et al.  Identification and Distribution of Fibrinogen, Fibrin, and Fibrin(ogen) Products in Atherosclerosis: Use of Monoclonal Antibodies , 1989, Arteriosclerosis.

[111]  M J Davies,et al.  Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. , 1985, British heart journal.

[112]  Walter L. Henry,et al.  Intravascular Ultrasound Imaging of Human Coronary Arteries In Vivo: Analysis of Tissue Characterizations With Comparison to In Vitro Histological Specimens , 1991, Circulation.

[113]  K. Lipscomb,et al.  Effects of coronary stenoses on coronary flow reserve and resistance. , 1974, The American journal of cardiology.

[114]  C. Zarins,et al.  Compensatory enlargement of human atherosclerotic coronary arteries. , 1987, The New England journal of medicine.

[115]  M. Davies Color atlas of cardiovascular pathology , 1986 .

[116]  R. Detrano,et al.  Coronary calcium and atherosclerosis by ultrafast computed tomography in asymptomatic men and women: relation to age and risk factors. , 1994, American heart journal.

[117]  W D Wagner,et al.  A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1994, Circulation.

[118]  C. de Burbure,et al.  The distribution of ceroid in human atherosclerosis , 1985, The Journal of pathology.

[119]  H. Weiss,et al.  Cell constitution and characteristics of human atherosclerotic plaques selectively removed by percutaneous atherectomy. , 1989, Atherosclerosis.

[120]  J. Salonen,et al.  Autoantibody against oxidised LDL and progression of carotid atherosclerosis , 1992, The Lancet.

[121]  A. Pomerance,et al.  Peri-arterial mast cells in coronary atheroma and thrombosis. , 1958, The Journal of pathology and bacteriology.

[122]  S. Y. Yu,et al.  Calcification processes in atherosclerosis. , 1974, Advances in experimental medicine and biology.

[123]  D H Blankenhorn,et al.  A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. , 1992, Circulation.

[124]  J. Guyton,et al.  Development of the atherosclerotic core region. Chemical and ultrastructural analysis of microdissected atherosclerotic lesions from human aorta. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[125]  M. Aviram,et al.  Platelet Lipoprotein Interactions , 1988, Seminars in thrombosis and hemostasis.

[126]  J. Saulnier,et al.  Human aortic elastin from normal individuals and atherosclerotic patients: lipid and cation contents; susceptibility to elastolysis. , 1991, Clinica chimica acta; international journal of clinical chemistry.

[127]  S. Srinivasan,et al.  Complexes of low-density lipoproteins and arterial proteoglycan aggregates promote cholesteryl ester accumulation in mouse macrophages. , 1985, Biochimica et biophysica acta.

[128]  W. Janowitz,et al.  Differences in prevalence and extent of coronary artery calcium detected by ultrafast computed tomography in asymptomatic men and women. , 1993, The American journal of cardiology.

[129]  E. Falk Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. , 1985, Circulation.

[130]  Blankenhorn Dh,et al.  The accuracy of arteriography and ultrasound imaging for atherosclerosis measurement. A review. , 1982 .

[131]  N. Pandian,et al.  Detection of intraarterial thrombus by intravascular high frequency two-dimensional ultrasound imaging in vitro and in vivo studies. , 1990, The American journal of cardiology.

[132]  P. Iverius The interaction between human plasma lipoproteins and connective tissue glycosaminoglycans. , 1972, The Journal of biological chemistry.

[133]  K. Yoshida,et al.  The antiproliferative activity of arterial heparan sulfate resides in domains enriched with 2-O-sulfated uronic acid residues. , 1992, The Journal of biological chemistry.

[134]  G. Bondjers,et al.  Modification of copper-catalyzed oxidation of low density lipoprotein by proteoglycans and glycosaminoglycans. , 1991, Journal of lipid research.

[135]  M J Davies,et al.  Potential errors in the estimation of coronary arterial stenosis from clinical arteriography with reference to the shape of the coronary arterial lumen. , 1986, British heart journal.

[136]  S Glagov,et al.  Differential enlargement of artery segments in response to enlarging atherosclerotic plaques. , 1988, Journal of vascular surgery.

[137]  Scanu Am Lp(a) as a marker for coronary heart disease risk. , 1991 .

[138]  J. Skepper,et al.  Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. , 1995, Atherosclerosis.

[139]  W. Roberts,et al.  Coronary artery narrowing in coronary heart disease: comparison of cineangiographic and necropsy findings. , 1979, Annals of internal medicine.

[140]  D. Heinegård,et al.  Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. , 1984, The Biochemical journal.

[141]  A. Tamburro,et al.  Interactions of human and bovine elastins with lipids: their proteolysis by elastase. , 1983, Connective tissue research.

[142]  D. Kramsch,et al.  The protein and lipid composition of arterial elastin and its relationship to lipid accumulation in the atherosclerotic plaque. , 1971, The Journal of clinical investigation.

[143]  U. Welsch,et al.  Results of Directional Peripheral Atherectomy with Reference to Histology, Histochemistry, and Ultrastructure , 1993, Angiology.

[144]  S. Coughlin,et al.  Monocyte chemoattractant protein-1 in human atheromatous plaques. , 1991, The Journal of clinical investigation.

[145]  S. Schnitt,et al.  Histololfic analysis of directional coronary atherectomy samples , 1993 .

[146]  Elspeth B. Smith,et al.  The influence of age and atherosclerosis on the chemistry of aortic intima , 1965 .

[147]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[148]  A. Ooshima Collagen alpha B chain: increased proportion in human atherosclerosis. , 1981, Science.

[149]  J L Witztum,et al.  Lipoproteins and atherogenesis. Current concepts. , 1990, JAMA.

[150]  J. Albers,et al.  Lipid Lowering and Plaque Regression New Insights Into Prevention of Plaque Disruption and Clinical Events in Coronary Disease , 1993, Circulation.

[151]  D. Hajjar,et al.  Eicosanoids in regulation of arterial smooth muscle cell phenotype, proliferative capacity, and cholesterol metabolism. , 1989, Arteriosclerosis.